Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China · Delayed Price · Currency is CNY

11.71

+0.03 (0.26%)

Jul 13, 2026, 3:05 PM CST

-10.88% (1Y)

Market Cap	8.89B -2.7%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	43.25
Forward PE	24.25
Dividend	0.11 (0.94%)
Ex-Dividend Date	Jun 1, 2026

Volume	13,757,094
Open	11.69
Previous Close	11.68
Day's Range	11.08 - 12.05
52-Week Range	10.42 - 20.37
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1993

Employees 5,479

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300171

Full Company Profile

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Financial Statements